Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 3506 | 4.15 |
09:34 ET | 4197 | 4.15 |
09:36 ET | 2010 | 4.07 |
09:38 ET | 100 | 4.07 |
09:39 ET | 5992 | 4.0725 |
09:41 ET | 8701 | 4.0705 |
09:43 ET | 8509 | 4.065 |
09:45 ET | 400 | 4.07 |
09:48 ET | 175 | 4.05 |
09:50 ET | 6800 | 4.04 |
09:52 ET | 600 | 4.05 |
09:56 ET | 400 | 4.05 |
09:59 ET | 100 | 4.05 |
10:01 ET | 1621 | 4.08 |
10:08 ET | 100 | 4.07 |
10:10 ET | 7958 | 4.05 |
10:12 ET | 9462 | 4.0309 |
10:14 ET | 6450 | 4.0214 |
10:15 ET | 800 | 4.03 |
10:17 ET | 1889 | 4.035 |
10:19 ET | 1200 | 4.035 |
10:21 ET | 2531 | 4.031206 |
10:24 ET | 19417 | 4.015 |
10:26 ET | 1300 | 4.035 |
10:28 ET | 2100 | 4.025 |
10:30 ET | 8500 | 4.0199 |
10:32 ET | 7216 | 4.005 |
10:33 ET | 12175 | 3.995 |
10:35 ET | 600 | 3.995 |
10:37 ET | 14949 | 3.99 |
10:39 ET | 2410 | 4.01 |
10:42 ET | 916 | 3.995 |
10:44 ET | 600 | 4.005 |
10:46 ET | 600 | 4.005 |
10:48 ET | 11014 | 3.975 |
10:50 ET | 2788 | 3.965 |
10:51 ET | 4930 | 3.979871 |
10:53 ET | 2200 | 3.9801 |
10:55 ET | 21093 | 3.99 |
10:57 ET | 4415 | 3.955 |
11:00 ET | 22773 | 3.955 |
11:02 ET | 21097 | 3.965 |
11:04 ET | 4200 | 3.975 |
11:06 ET | 3009 | 3.955 |
11:08 ET | 450 | 3.95 |
11:09 ET | 4076 | 3.945 |
11:11 ET | 200 | 3.945 |
11:13 ET | 3314 | 3.9592 |
11:15 ET | 5300 | 3.955 |
11:18 ET | 800 | 3.955 |
11:20 ET | 200 | 3.955 |
11:22 ET | 1300 | 3.955 |
11:24 ET | 100 | 3.955 |
11:26 ET | 5574 | 3.965 |
11:27 ET | 1400 | 3.965 |
11:29 ET | 1300 | 3.965 |
11:31 ET | 1100 | 3.965 |
11:33 ET | 6000 | 3.97 |
11:36 ET | 4950 | 3.985 |
11:38 ET | 1552 | 3.985 |
11:40 ET | 326 | 3.985 |
11:42 ET | 1500 | 3.995 |
11:44 ET | 100 | 3.995 |
11:45 ET | 100 | 3.9999 |
11:47 ET | 19281 | 3.995 |
11:49 ET | 1400 | 3.995 |
11:51 ET | 15814 | 3.995 |
11:54 ET | 300 | 3.995 |
11:58 ET | 1100 | 3.995 |
12:00 ET | 87359 | 3.995 |
12:02 ET | 18385 | 3.99 |
12:03 ET | 2300 | 3.995 |
12:05 ET | 2200 | 3.995 |
12:09 ET | 4451 | 3.995 |
12:12 ET | 100 | 3.995 |
12:18 ET | 775 | 3.995 |
12:20 ET | 100 | 3.995 |
12:21 ET | 2400 | 3.995 |
12:23 ET | 200 | 3.995 |
12:25 ET | 1400 | 3.995 |
12:27 ET | 5693 | 3.985 |
12:30 ET | 500 | 3.975 |
12:32 ET | 100 | 3.97 |
12:34 ET | 12268 | 3.965 |
12:36 ET | 6403 | 3.98 |
12:39 ET | 400 | 3.985 |
12:41 ET | 600 | 3.985 |
12:43 ET | 6783 | 3.985 |
12:45 ET | 200 | 3.985 |
12:48 ET | 3268 | 3.98 |
12:52 ET | 300 | 3.98 |
12:54 ET | 2830 | 3.98 |
12:56 ET | 4832 | 3.985 |
12:57 ET | 100 | 3.985 |
12:59 ET | 400 | 3.99 |
01:01 ET | 400 | 3.99 |
01:03 ET | 1800 | 3.985 |
01:06 ET | 2199 | 3.98 |
01:12 ET | 2087 | 3.965 |
01:14 ET | 5400 | 3.965 |
01:15 ET | 200 | 3.965 |
01:17 ET | 1400 | 3.965 |
01:19 ET | 300 | 3.965 |
01:21 ET | 800 | 3.9662 |
01:24 ET | 700 | 3.965 |
01:26 ET | 70977 | 3.995 |
01:28 ET | 300 | 3.995 |
01:30 ET | 21990 | 3.995 |
01:32 ET | 4600 | 3.995 |
01:33 ET | 19738 | 3.995 |
01:35 ET | 16990 | 3.995 |
01:37 ET | 400 | 3.995 |
01:39 ET | 400 | 3.995 |
01:42 ET | 700 | 3.995 |
01:44 ET | 100 | 3.995 |
01:46 ET | 700 | 3.99 |
01:48 ET | 8952 | 3.995 |
01:50 ET | 11385 | 3.995 |
01:51 ET | 5700 | 3.995 |
01:53 ET | 200 | 3.995 |
01:55 ET | 4900 | 3.995 |
01:57 ET | 14896 | 3.995 |
02:00 ET | 850 | 3.9988 |
02:02 ET | 162742 | 3.99 |
02:04 ET | 11100 | 3.985 |
02:06 ET | 900 | 3.985 |
02:08 ET | 1300 | 3.985 |
02:09 ET | 10300 | 3.985 |
02:11 ET | 300 | 3.985 |
02:13 ET | 1682 | 3.985 |
02:15 ET | 616 | 3.9867 |
02:18 ET | 1200 | 3.9861 |
02:20 ET | 10008 | 3.995 |
02:24 ET | 23643 | 4.025 |
02:26 ET | 1062 | 4.035 |
02:27 ET | 4430 | 4.045 |
02:29 ET | 200 | 4.055 |
02:31 ET | 200 | 4.055 |
02:33 ET | 100 | 4.055 |
02:36 ET | 5497 | 4.08 |
02:38 ET | 28063 | 4.065 |
02:40 ET | 200 | 4.065 |
02:42 ET | 2619 | 4.075 |
02:44 ET | 2692 | 4.095 |
02:45 ET | 4056 | 4.1 |
02:47 ET | 1958 | 4.105 |
02:49 ET | 800 | 4.105 |
02:51 ET | 1300 | 4.11 |
02:54 ET | 1050 | 4.105 |
02:56 ET | 1100 | 4.105 |
02:58 ET | 200 | 4.105 |
03:00 ET | 200 | 4.105 |
03:03 ET | 8087 | 4.105 |
03:05 ET | 2125 | 4.125 |
03:07 ET | 100 | 4.125 |
03:12 ET | 3188 | 4.135 |
03:14 ET | 700 | 4.135 |
03:16 ET | 900 | 4.135 |
03:18 ET | 5269 | 4.1311 |
03:20 ET | 700 | 4.14 |
03:21 ET | 7359 | 4.125 |
03:23 ET | 1400 | 4.145 |
03:25 ET | 500 | 4.1435 |
03:27 ET | 250 | 4.1489 |
03:30 ET | 1000 | 4.145 |
03:32 ET | 12127 | 4.135 |
03:34 ET | 2600 | 4.135 |
03:36 ET | 422 | 4.135 |
03:38 ET | 5954 | 4.14 |
03:39 ET | 100 | 4.14 |
03:41 ET | 540 | 4.14 |
03:45 ET | 2100 | 4.145 |
03:50 ET | 3124 | 4.1542 |
03:52 ET | 6766 | 4.145 |
03:54 ET | 5450 | 4.14 |
03:56 ET | 4139 | 4.155 |
03:57 ET | 10530 | 4.1601 |
03:59 ET | 51418 | 4.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 641.6M | -12.7x | --- |
Immunome Inc | 811.9M | -2.4x | --- |
IGM Biosciences Inc | 860.1M | -3.9x | --- |
Perspective Therapeutics Inc | 851.6M | -9.1x | --- |
Oruka Therapeutics Inc | 866.2M | -4.1x | --- |
CARGO Therapeutics Inc | 838.7M | -5.3x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $641.6M |
---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-0.33 |
Book Value | $0.47 |
P/E Ratio | -12.7x |
Price/Sales (TTM) | 61.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.